OptimizeRX (OPRX) PT Lowered to $14 at Stifel After Guidance Cut

May 13, 2026 7:18 AM

Stifel analyst David Grossman lowered the price target on OptimizeRX (NASDAQ: OPRX) to $14.00 (from $17.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found